{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:16:28Z","timestamp":1779279388174,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cyto.2026.157164","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:36:42Z","timestamp":1778175402000},"page":"157164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genetic and inflammatory interplay between IL1B (-511C\/T) polymorphism and diabetic nephropathy in type 2 diabetes"],"prefix":"10.1016","volume":"203","author":[{"given":"Maysaa El Sayed","family":"Zaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Hosney Mohammed","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amro Abdel-Hamid","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Ghaleb","family":"Essa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2026.157164_bb0005","article-title":"New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era","volume":"15","author":"Hu","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157164_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCRESAHA.121.320239","article-title":"Tubular IL-1\u03b2 induces salt sensitivity in diabetes by activating renal macrophages","volume":"131","author":"Veiras","year":"2022","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.cyto.2026.157164_bb0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1681\/ASN.2016040453","article-title":"IL-1 inhibition and vascular function in CKD","volume":"28","author":"Nowak","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157164_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12020-009-9268-x","article-title":"Interleukin 1 beta (IL-1\u03b2) promoter C [\u2212511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome","volume":"37","author":"Mu","year":"2010","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.cyto.2026.157164_bb0025","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ckj\/sfaa077","article-title":"The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies","volume":"13","author":"Tziastoudi","year":"2020","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.cyto.2026.157164_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9661823","article-title":"Association of interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms and plasma levels with diabetic nephropathy","volume":"2022","author":"Liao","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.cyto.2026.157164_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13098-025-01667-y","article-title":"Association of the interaction between interleukin-1\u03b2 gene polymorphism and smoking status with the diabetic nephropathy risk in a Chinese Han population","volume":"17","author":"Xie","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"issue":"2","key":"10.1016\/j.cyto.2026.157164_bb0040","article-title":"Cytokine profiling for Egyptian diabetic patients with nephropathy","volume":"5","author":"Abdel Gaffar","year":"2022","journal-title":"J. Med. Sci. Res."},{"key":"10.1016\/j.cyto.2026.157164_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1397301","article-title":"Exploring the role of NLRP3 inflammasome in diabetic nephropathy and the advancements in herbal therapeutics","volume":"15","author":"Jin","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.cyto.2026.157164_bb0050","first-page":"345","article-title":"Interleukin-1\u03b2 (\u2212511C\/T) and IL-6 (\u2212174G\/C) gene polymorphisms and cardiovascular risk in Egyptian patients on maintenance hemodialysis","volume":"14","author":"Kandil","year":"2013","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"12","key":"10.1016\/j.cyto.2026.157164_bb0055","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0300-8932(05)74065-3","article-title":"A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results","volume":"58","author":"Zimmet","year":"2005","journal-title":"Rev. Esp. Cardiol."},{"issue":"Suppl 5S","key":"10.1016\/j.cyto.2026.157164_bb0060","first-page":"S1","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2022","journal-title":"Kidney Int."},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2026.157164_bb0065","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.2337\/dc24-S011","article-title":"11. Chronic kidney Disease and risk management: standards of Care in Diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.cyto.2026.157164_bb0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cyto.2026.157164_bb0075","author":"OpenEpi"},{"key":"10.1016\/j.cyto.2026.157164_bb0080","series-title":"Sample Size Tables for Clinical Studies","author":"Machin","year":"2009"},{"issue":"20","key":"10.1016\/j.cyto.2026.157164_bb0085","first-page":"7861","article-title":"Pathogenic pathways and therapeutic approaches in diabetic nephropathy: role of inflammation and oxidative stress","volume":"77","author":"Rayego-Mateos","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.cyto.2026.157164_bb0090","first-page":"565","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"18","author":"Navarro-Gonz\u00e1lez","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cyto.2026.157164_bb0095","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12882-020-01960-0","article-title":"Renal expression of cytokines and chemokines in diabetic nephropathy","volume":"21","author":"Ara\u00fajo","year":"2020","journal-title":"BMC Nephrol."},{"issue":"6","key":"10.1016\/j.cyto.2026.157164_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/08820139.2019.1595642","article-title":"Interleukin-1\u03b2 gene (IL1B) polymorphism and risk of developing diabetic nephropathy","volume":"48","author":"Buraczynska","year":"2019","journal-title":"Immunol. Investig."},{"issue":"7","key":"10.1016\/j.cyto.2026.157164_bb0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/dna.2013.2204","article-title":"Association between the interleukin-1\u03b2 gene (IL1B) C-511T polymorphism and the risk of diabetic nephropathy in type 2 diabetes: a candidate-gene association study","volume":"33","author":"Stefanidis","year":"2014","journal-title":"DNA Cell Biol."},{"issue":"3","key":"10.1016\/j.cyto.2026.157164_bb0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ckj\/sfx008","article-title":"A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy","volume":"10","author":"Tziastoudi","year":"2017","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.cyto.2026.157164_bb0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10719-021-10035-7","article-title":"The association between serum interleukin-1 beta and heparin sulphate in diabetic nephropathy patients","volume":"38","author":"Jiang","year":"2021","journal-title":"Glycoconj. J."},{"issue":"1","key":"10.1016\/j.cyto.2026.157164_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ki.2014.322","article-title":"Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells","volume":"87","author":"Sakai","year":"2015","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cyto.2026.157164_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020458","article-title":"Inflammatory targets in diabetic nephropathy","volume":"9","author":"Donate-Correa","year":"2020","journal-title":"J. Clin. Med."},{"issue":"15","key":"10.1016\/j.cyto.2026.157164_bb0130","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1\u2013receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2026.157164_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01223","article-title":"Interleukin-1\u03b2 inhibition for chronic kidney disease in obese mice with type 2 diabetes","volume":"10","author":"Lei","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:59:12Z","timestamp":1779278352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S1043466626000591"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157164","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and inflammatory interplay between IL1B (-511C\/T) polymorphism and diabetic nephropathy in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157164"}}